Table 5.

Multivariate analysis for presence of teratoma in RPLND specimen excluding patients that received BEP x 4 for good risk GCT (n=410)

Variable	OR	95% CI	p-value
Clinical Stage
I	Ref
IIA	0.9	0.4, 2.3	0.8
IIB/C	0.4	0.2, 0.8	0.01
III	0.2	0.08, 0.5	0.001
Any Yolk Sac	1.2	0.7, 2.1	0.4
Any Teratoma	4.3	2.6, 7.2	<0.001
Pre-surgery RP node size	1.6	1.3, 1.9	<0.001
Year of surgery (before 1999 vs. after 1999)	0.7	0.4, 1.2	0.2
Chemotherapy (EP vs. BEP)	3.7	1.5, 8.9	0.004